|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/03/11 Clorox Co/DE 10-Q 9/30/11 50:2.6M DG3/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 295K
2: EX-10.21 Amendment No. 1 to the Clorox Company Supplemental HTML 22K
Executive Retirement Plan
3: EX-31.1 Certification by the Chief Executive Officer of HTML 23K
the Company
4: EX-31.2 Certification by the Chief Financial Officer of HTML 23K
the Company
5: EX-32 Certification by the Chief Executive Officer and HTML 18K
Chief Financial Officer
15: R1 Document And Entity Information HTML 33K
47: R2 Condensed Consolidated Statements Of Earnings HTML 125K
12: R3 Condensed Consolidated Balance Sheets HTML 131K
13: R4 Condensed Consolidated Balance Sheets HTML 43K
(Parenthetical)
40: R5 Condensed Consolidated Statements Of Cash Flows HTML 126K
28: R6 Interim Financial Statements HTML 25K
43: R7 Inventories, Net HTML 27K
21: R8 Other Liabilities HTML 23K
29: R9 Net Earnings Per Share HTML 36K
32: R10 Comprehensive Income HTML 33K
37: R11 Income Taxes HTML 25K
17: R12 Retirement Income And Health Care Benefit Plans HTML 34K
27: R13 Contingencies And Guarantees HTML 23K
23: R14 Segment Results HTML 45K
25: R15 Fair Value Measurements And Financial Instruments HTML 57K
44: R16 Interim Financial Statements (Policy) HTML 22K
20: R17 Inventories, Net (Tables) HTML 24K
36: R18 Other Liabilities (Tables) HTML 22K
24: R19 Net Earnings Per Share (Tables) HTML 37K
46: R20 Comprehensive Income (Tables) HTML 27K
38: R21 Retirement Income And Health Care Benefit Plans HTML 24K
(Tables)
41: R22 Segment Results (Tables) HTML 33K
14: R23 Fair Value Measurements And Financial Instruments HTML 45K
(Tables)
42: R24 Inventories, Net (Schedule Of Inventories, Net) HTML 36K
(Details)
19: R25 Other Liabilities (Schedule Of Other Liabilities) HTML 27K
(Details)
16: R26 Net Earnings Per Share (Narrative) (Details) HTML 24K
18: R27 Net Earnings Per Share (Reconciliation Of Net HTML 54K
Earnings And Weighted Average Number Of Shares
Outstanding) (Details)
33: R28 Net Earnings Per Share (Schedule Of Reconciliation HTML 27K
Of Share Repurchases) (Details)
39: R29 Comprehensive Income (Schedule Of Components Of HTML 57K
Comprehensive Income) (Details)
35: R30 Income Taxes (Details) HTML 30K
31: R31 Retirement Income And Health Care Benefit Plans HTML 24K
(Narrative) (Details)
26: R32 Retirement Income And Health Care Benefit Plans HTML 37K
(Components Of Net Periodic Benefit Cost)
(Details)
34: R33 Contingencies And Guarantees (Details) HTML 25K
45: R34 Segment Results (Details) HTML 28K
22: R35 Fair Value Measurements And Financial Instruments HTML 40K
(Narrative) (Details)
48: R36 Fair Value Measurements And Financial Instruments HTML 53K
(Details)
49: XML IDEA XML File -- Filing Summary XML 71K
50: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 304K
6: EX-101.INS XBRL Instance -- clx-20110930 XML 445K
10: EX-101.CAL XBRL Calculations -- clx-20110930_cal XML 132K
11: EX-101.DEF XBRL Definitions -- clx-20110930_def XML 95K
9: EX-101.LAB XBRL Labels -- clx-20110930_lab XML 587K
8: EX-101.PRE XBRL Presentations -- clx-20110930_pre XML 356K
7: EX-101.SCH XBRL Schema -- clx-20110930 XSD 90K
30: ZIP XBRL Zipped Folder -- 0001206774-11-002394-xbrl Zip 60K
| I, Daniel J. Heinrich, certify that: | ||||
| 1. | I have reviewed this quarterly report on Form 10-Q of The Clorox Company; | |||
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |||
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |||
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | |||
| a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||
| b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||
| c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||
| d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. | |||
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): | |||
| a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |||
| b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. | |||
| Date: November 3, 2011 | |
| /s/ Daniel J. Heinrich | |
| Daniel J. Heinrich Executive Vice President - Chief Financial Officer |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/3/11 | SC 13D/A | ||
| For Period end: | 9/30/11 | 4, DEF 14A, DEFA14A | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/10/23 Clorox Co./DE 10-K 6/30/23 133:15M 8/10/22 Clorox Co./DE 10-K 6/30/22 129:15M 8/10/21 Clorox Co./DE 10-K 6/30/21 131:16M 8/13/20 Clorox Co./DE 10-K 6/30/20 133:19M |